| Authors: |
Ferrari N; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK.; Astex Pharmaceuticals, 436 Cambridge Science Park, Cambridge, CB4 0QA, United Kingdom., Ranftl R; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK., Chicherova I; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK., Slaven ND; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK., Moeendarbary E; Department of Mechanical Engineering, University College London, London, WC1E 7JE, UK.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, USA., Farrugia AJ; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK., Lam M; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK., Semiannikova M; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK., Westergaard MCW; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, 2730, Herlev, Denmark., Tchou J; Abramson Cancer Center and the Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Magnani L; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK., Calvo F; Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London, SW3 6JB, UK. calvof@unican.es.; Instituto de Biomedicina y Biotecnologia de Cantabria, c/ Albert Einstein 22, E39011, Santander, Spain. calvof@unican.es. |
